Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1953 1
1954 1
1958 2
1960 3
1963 5
1965 2
1966 1
1967 1
1968 2
1969 2
1970 2
1971 1
1973 3
1975 2
1977 1
1978 1
1980 1
1981 1
1983 1
1986 1
1987 2
1991 2
1992 1
1993 1
1995 1
1998 1
2004 1
2006 2
2007 3
2008 5
2009 7
2010 2
2011 2
2012 1
2013 1
2014 2
2015 3
2016 1
2017 2
2018 3
2019 1
2020 2
2021 5
2022 3
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.
Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez Moreno HL, Hu X, Jhaveri K, Krivorotko P, Loibl S, Morales Murillo S, Okera M, Park YH, Sohn J, Toi M, Tokunaga E, Yousef S, Zhukova L, de Bruin EC, Grinsted L, Schiavon G, Foxley A, Rugo HS; CAPItello-291 Study Group. Turner NC, et al. N Engl J Med. 2023 Jun 1;388(22):2058-2070. doi: 10.1056/NEJMoa2214131. N Engl J Med. 2023. PMID: 37256976 Clinical Trial.
Monocyte programming by cancer therapy.
Patysheva M, Frolova A, Larionova I, Afanas'ev S, Tarasova A, Cherdyntseva N, Kzhyshkowska J. Patysheva M, et al. Among authors: tarasova a. Front Immunol. 2022 Oct 20;13:994319. doi: 10.3389/fimmu.2022.994319. eCollection 2022. Front Immunol. 2022. PMID: 36341366 Free PMC article. Review.
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
Balmaña J, Fasching PA, Couch FJ, Delaloge S, Labidi-Galy I, O'Shaughnessy J, Park YH, Eisen AF, You B, Bourgeois H, Gonçalves A, Kemp Z, Swampillai A, Jankowski T, Sohn JH, Poddubskaya E, Mukhametshina G, Aksoy S, Timcheva CV, Park-Simon TW, Antón-Torres A, John E, Baria K, Gibson I, Gelmon KA; LUCY investigators. Balmaña J, et al. Breast Cancer Res Treat. 2024 Apr;204(2):237-248. doi: 10.1007/s10549-023-07165-x. Epub 2023 Dec 19. Breast Cancer Res Treat. 2024. PMID: 38112922 Free PMC article. Clinical Trial.
Scanning the Future of Medical Imaging.
Alexander A, McGill M, Tarasova A, Ferreira C, Zurkiya D. Alexander A, et al. Among authors: tarasova a. J Am Coll Radiol. 2019 Apr;16(4 Pt A):501-507. doi: 10.1016/j.jacr.2018.09.050. Epub 2018 Dec 3. J Am Coll Radiol. 2019. PMID: 30522844 Free article.
95 results